The latest issue of the BIORIMA Newsletter (February 2021) is out now and downloadable here
The Newsletter kicks off with an invitation to the demonstration of the BIORIMA Integrated Risk Management (IRM) Framework and Decision Support System (DSS) using real case examples.
Register here: http://tinyurl.com/BIORIMADEMO
Not only will you have the opportunity to find out about the purpose, principles and potential applications of the IRM and the DSS we are developing, but also you will be able to validate the systems and provide feedback using a questionnaire.
Session 1: Thursday, 25th February 15:30-17:00 CET
Session 2: Friday, 26th February 9:30-11:00 CET
Find out how you, developers, manufacturers, and users of Nano-Biomaterials (NBM) and associated Medical Devices (MD) and Advanced Therapeutic Medicinal Products (ATMP) can benefit from these main BIORIMA output and results.
For more information, contact email@example.com
The Newsletter continues with updates from the COVID-19 Task Force and an example of BIORIMA'S accelerated innovation concept in practice. With NanoTOX 21 rapidly approaching, there is a list of abstracts and contacts for further exploration. Announcements include an open call from INNO4COV, an update on NanoTOX21 arrangements, and details of the forthcoming NanoSafety Training School in June.
As always, we hope you find the news items of interest, and please register for the IRM/DSS webinar - we look forward to seeing you there.